This webinar will highlight updates in cancer treatment associated with genomic and genetic testing and address challenges and benefits of improving clinical trial enrollment for patients with hereditary cancer.

  1. Summarize tumor BRCA mutations and their implications in treatments beyond ovarian cancer.
  2. Examine barriers to enrolling individuals with inherited mutations into clinical research.
  3. Identify resources available to address challenges in engagement and clinical trial enrollment.


Sarah Pass, MMSc, CGC- Myriad Genetics. Inc

Sue Friedman, DVM- Executive Director of Facing Our Risk of Cancer Empowered (FORCE)

This nursing continuing professional development activity is approved for 1.25 contact hours from Oregon Nurses Association (ONA), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).  Contact hours will be awarded to participants who view the entire program recording and complete the post-activity survey.

Click here after viewing the webinar to complete the survey:

Take Survey

Please pay close attention to the instructions for receiving your certificate at the end of this survey. Once you have completed this survey in entirety you will have an option to print or save the image of the certificate. We recommend that you complete this from a desktop or your laptop computer for best quality and options for saving this file.

Please read the instructions below carefully to obtain your certificate.

Please right click on the image of the certificate below and select “save as an image”. You can name the file and save to your computer to access later or to print. If you encounter an error message when downloading to your computer, right click the download tab and click “resume”. This should correct this issue.

IMPORTANT: You must save the image at this time to obtain this certificate for your records. Certificates will not be emailed.

***You must complete the webinar and survey no later than January 13th, 2025 to claim credit***

Myriad Genetics Lab has approved exemption for commercial interest as a diagnostic laboratory. There are no conflicts of interest with individuals in the position to control content for this activity.

Questions or comments?

Webinar Questions